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Abstract
Cardiac aspergilloma is exceptionally rare with only a handful of cases reported and majority of
them being in immunocompromised patients. Here, we present a case of cardiac aspergilloma
involving the right and left ventricle in an immunocompetent patient that initially presented
with acute limb ischemia. He was later found to have a cardiac mass with histopathological
diagnosis confirming Aspergillus species. Despite aggressive medical and surgical
interventions, the patient had an unfavorable outcome due to low suspicion of invasive fungal
endocarditis given his immunocompetent status. Cardiac aspergilloma should remain in the
differential diagnosis of immunocompetent patients as early clinical suspicion will result in
early treatment and decreased mortality. Novel therapies are required to decrease mortality in
the future from this fatal disease.
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Aspergillus is a common fungus that is present in the environment and is known to cause fatal
disease, particularly in immunocompromised hosts. Fungal endocarditis is rare and accounts
for <2% documented cases of infective endocarditis of which only 20-25% are caused by
aspergillus species [1]. Invasive aspergillus involving heart valves and cardiac chambers is
exceptionally rare with only a handful of cases reported and majority of them being in
immunocompromised patients. Here, we present a case of cardiac aspergilloma involving the
right and left ventricle in an immunocompetent patient that initially presented with acute limb
ischemia.
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Case Presentation
A 19-year-old male with no known past medical history presented to the hospital with a twoday history of right-sided leg pain with yellowish to bluish discoloration. The patient was
tachycardic, normotensive, and afebrile. On examination, he was found to have a cool right
lower extremity, delayed capillary refill, and diminished femoral, popliteal, posterior tibial, and
dorsalis pedis pulses. The patient had a normal appearance of the contralateral extremity with
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palpable pulses. On auscultation of his heart, he did not have any murmurs, rubs, or gallops. No
focal neurological deficits were appreciated on examination. Laboratory workup revealed a
normal complete blood picture and comprehensive metabolic panel, erythrocyte sedimentation
rate 115, c-reactive protein 13.5, procalcitonin 0.518, and negative serology for HIV, hepatitis B,
and C. Autoimmune workup with antinuclear antibody (ANA), anti-double stranded DNA
(dsDNA), complement C3/C4, and antiphospholipid antibodies was also negative.
Electrocardiogram showed sinus tachycardia without acute ischemic changes. Chest X-ray did
not show an acute cardiopulmonary process. Bilateral arterial and venous dopplers were done
which showed a thrombus in the right femoral artery.
The patient was taken to the operating room and successfully underwent right femoral
embolectomy for acute limb ischemia. On the first postoperative day, the patient developed
blurry vision in his left eye. A CT head without contrast showed no evidence of acute
intracranial pathology. Due to concerns for cardiac source of systemic embolization a
transthoracic echocardiogram (TTE) was done which showed a 12 × 10 mm mass hanging from
the sub-aortic septum extending into the left ventricular outflow tract (LVOT) (Figure 1).

FIGURE 1: Parasternal long axis view on transthoracic
echocardiogram showing a mass extending into the left
ventricular outflow tract (LVOT).

There was clinical suspicion for a cardiac rhabdomyosarcoma so further imaging was obtained
to delineate the mass. Cardiac MRI showed a 37 x 45 mm complex irregular mass in the basal
septum, growing towards both ventricles, eroding the left ventricle (LV) and further bifurcating
into two linear extensions. One of the linear structures was freely mobile in the LVOT. The area
of the mass in the right ventricle (RV) was calculated at 15.5 cm 2 with fronds protruding into
the RV cavity. MRI findings were read as consistent with sarcoma and recommended further
work with a biopsy for confirmation. The patient subsequently underwent excision of the mass
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and the specimen was sent for histopathology.
The patient was extubated to nasal cannula within 12 hours postoperatively. Histopathology of
the tissue obtained in the operating room showed numerous septate and branching fungal
hyphae which were consistent with Aspergillus species (Figure 2). Infectious disease was
consulted and he was initiated on liposomal amphotericin B. On his first post-operative day, he
developed an acute change in his mental status and was subsequently found to have septic
embolus to his brain on MRI. The patient was made comfort measures only and passed away
shortly after.

FIGURE 2: Histological examination showing numerous septate
and branching fungal hyphae consistent with Aspergillus
species.

Discussion
Aspergillus is a common fungus that is present in the environment and easily inhaled; however,
healthy individuals have a natural immunity to the aspergillus spores. Aspergillus infections
account for 0.1-3.9% of annual cases in immunocompromised patients, out of which only 0.76% of patients develop cardiac involvement due to the fungal infection [2]. The common
predisposing risk factors of an Aspergillus infection are immunocompromised status, damaged
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lungs, prosthetic valves, rheumatic heart disease, long-term placement of a central venous
catheter, total parenteral nutrition, and IV drug use [3-4]. Cardiac aspergilloma as presented in
our case is a rare condition that is not associated with any of the above predisposing risk
factors, this unique presentation is only seen in 3.4% of total cases and has not been commonly
reported in literature [5].
The common etiologic agents of infective endocarditis (IE) are bacteria and fungi. Candida
followed by Aspergillus are the two most common fungi responsible for fungal endocarditis [3].
Cardiac fungal infections with Aspergillus species have a high mortality rate due to the nature
of the disease, difficulty in early diagnosis, and high rates of systemic embolization. In patients
with aspergillus endocarditis, approximately 50% of blood cultures yield negative results as
Aspergillus species is not easily detected [3]. TTE is the first diagnostic test for patients
suspected of having IE with a sensitivity of 75% and specificity approaching 100%. However, a
negative test result does not preclude the diagnosis and a transesophageal echocardiogram
(TEE) is warranted [6]. Fungal vegetations are typically characterized as large, bulky, and highly
mobile, with an increased risk of embolic events most commonly affecting the brain, as seen in
our case. Cardiac MRI is a noninvasive method superior to TTE in diagnosis, differentiation,
and detection of extension of cardiac masses [7]. However, the test is not always required in the
diagnosis of cardiac aspergilloma. In our patient, TTE showed a large, mobile cardiac mass for
which the differential diagnosis included fungal etiology, thrombus, primary cardiac tumor,
myxoma, metastatic lesion, and lymphoma. In our patient, there was initial suspicion of cardiac
rhabdomyosarcoma after which a cardiac MRI was obtained to further delineate the mass. Final
diagnosis is best achieved by excision and biopsy of the mass. In our patient, the histologic
examination revealed fungal septate hyphae confirming Aspergillus species.
A multi-disciplinary effort involving cardiology, infectious disease, and cardiac surgery is
required in managing patients with cardiac aspergilloma given the complexity and high
mortality associated with the disease process. Most recent reviews as well as Infectious
Diseases Society of America (IDSA) guidelines favor both pharmacological and surgical
interventions for treatment of Aspergillus endocarditis early in the disease course to help
decrease poor outcomes and mortality which include compromising cardiac function and the
risk of embolic events [8]. Per IDSA, the recommended initial antifungal agents are liposomal
amphotericin B or voriconazole, followed by lifelong antifungal treatment postsurgical
intervention [9]. Yuan has proposed using caspofungin in addition to voriconazole and
amphotericin, however, the use of combining antifungal therapies has not been shown to be
superior to monotherapy [3,9]. In the described case, the patient underwent surgical excision of
the mass and was treated with systemic liposomal amphotericin B late in his hospital course, as
there was a low clinical suspicion of invasive aspergillus given his immunocompetent state. On
review of the current literature, only a small number of cases of cardiac aspergilloma have
previously been reported (Table 1) [4, 10-16].
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Author
(Year)
ChenMilhone
et al.
(2018)
[4]

Patient characteristics

62-year-old immunocompromised male with a
past medical history of prostatic
adenocarcinoma on chemotherapy.

Findings

Cardiac aspergilloma involving the native tricuspid valve,
right atrium and ventricle.

Soman
et al.
(2014)
[10]
Paul et
al.
(2012)

22-year-old immunocompetent male with a past
medical history of hepatitis B.

Aspergillosis extensively involving all four chambers, the
tricuspid and mitral valves of the heart.

60-year-old female with leukemia who had
undergone allogeneic stem cell transplantation

Invasive aspergillosis of the interventricular septum.

[11]
Alvarez
et al.
(2004)
[12]

12-year-old female with acute lymphoblastic
leukemia on chemotherapy.

Chou et
al.
(2013)

27-year-old man receiving chemotherapy for
acute myeloid leukemia.

[13]
Singla et
26-year-old male with a past medical history of
al.
polysubstance abuse who was being treated
(2011)
for complications of acute pancreatitis.
[14]
Cishek

40-year-old woman with a 12-year history of

et al.
(1996)
[15]

severe ulcerative colitis unresponsive to
treatment on high doses of prednisone and 6mercaptopurine.

DangTran et
al.
(2014)
[16]

68-year-old male liver transplant patient on
immunosuppressive therapy.

Left ventricular pedunculated mass that was detected by
echocardiographic study; at surgery, the presence
of Aspergillus terreus was confirmed.

A large right ventricular mass was detected on transthoracic
echocardiogram after surgical excision a specimen culture
yielded Aspergillus flavus.
A large mobile tricuspid valve aspergilloma obstructing the
right ventricular inlet, diagnosed incidentally on the second
postoperative day after laparoscopic pancreatic abscess
drainage.

Aspergillosis invading the myocardium and causing
widespread necrosis and infarction.

Isolated Aspergillosis Myocardial Abscesses

TABLE 1: Review of current literature describing reported cases of cardiac
aspergilloma.

Majority of the reported cases of cardiac aspergilloma have occurred in immunocompromised
patients and rarely in healthy individuals as observed in our patient. In all of the cases except
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for one, the outcome was unfavorable resulting in the death of the patient days or weeks after
diagnosis. Fungal endocarditis is associated with a mortality rate of at least 50% with an
average survival period of 11 days with a 30% recurrence rate in survivors [17]. Unfortunately,
our patient developed a septic embolus to his brain which ultimately led to his demise.

Conclusions
Cardiac aspergilloma is a rare disease with a high mortality rate despite aggressive
pharmacological and surgical interventions. It is rarely reported in immunocompetent patients
and carries a high mortality rate and often leads to unfavorable outcomes. Cardiac aspergilloma
should remain in the differential diagnosis of cardiac masses in immunocompetent patients as
early clinical suspicion will result in early treatment and decreased mortality. Survivors should
be closely followed due to high recurrence rates.
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